Breaking Business Biden Invokes Defense Production Act To Require Manufacture Of Baby Formula Ingredients Zachary Snowdon Smith Forbes Staff I cover breaking news for Forbes. May 18, 2022, 06:31pm EDT | Updated May 18, 2022, 07:19pm EDT Share to Facebook Share to Twitter Share to Linkedin Topline President Joe Biden is invoking the 1950 Defense Production Act (DPA) to make companies produce vital baby formula ingredients as part of a raft of new measures to lessen the ongoing national baby formula shortage , the White House announced Wednesday. Katie Wussler, a program coordinator at Mother & Child Education Center in Portland Oregon, checks … [+] the lot number on a donated can of Similac baby formula against a list of recalled cans on May 12, 2022. Nathan Howard/Getty Images Key Facts Enacted during the Korean War to avoid wartime shortages, the DPA enables the president to require companies to enter into contracts to produce materials considered necessary for national defense. The DPA also lets the president prohibit hoarding and profiteering from certain materials. Biden will invoke the PDA to order businesses to step up production of necessary baby formula ingredients and to direct those ingredients to formula manufacturers in order to accelerate the return of formula to store shelves, the White House said . Biden also ordered federal agencies to use Department of Defense commercial aircraft to fetch baby formula that meets U.S. standards from sites overseas, the White House announced . The Department of Defense will speed up the importing of baby formula by using contracts with air cargo lines to bypass usual freight routes, a measure also employed during the early months of the Covid-19 pandemic, the White House said . The announcement came two days after Abbott Laboratories, the formula manufacturer whose voluntary product recall in February helped trigger the nationwide shortage, laid out a plan to reopen a key formula plant and ease the shortage within as little as eight weeks. Key Background Abbott closed its Sturgis, Michigan, baby formula plant in February, after regulators launched an investigation into possible links between formula manufactured there and a string of infant bacterial infections and two deaths. By early May, stores had 43% less formula in stock and profiteers had begun to hoard remaining supplies, selling them online at a large markup, the New York Times reported. An investigation into the infections by the Centers for Disease Control and Prevention concluded last week and found no additional cases. Monday, Abbott announced it had reached an arrangement to reopen its Sturgis plant with the Food and Drug Administration’s approval. However, it could take well over a month before Abbott baby formula begins to reappear on shelves, the company said . Big Number 43%. That’s the proportion of total U.S. baby formula sales accounted for by Abbott, according to a 2011 Department of Agriculture report . Further Reading “Abbott Strikes Deal With FDA To Reopen Baby Formula Plant At Center Of National Shortage” (Forbes) Follow me on LinkedIn . Send me a secure tip . Zachary Snowdon Smith Editorial Standards Print Reprints & Permissions